10
Participants
Start Date
March 31, 2014
Primary Completion Date
April 30, 2014
Study Completion Date
January 31, 2015
Broccoli Sprout Extract (BSE)
"1. The first regimen will involve oral delivery and ingestion of 600 μmole doses of glucoraphanin-rich BSE (GRR-BSE), and will represent systemic delivery of sulforaphane to oral mucosa, due to the necessity to metabolize GRR-BSE in the gut.~2. The second regimen will involve oral delivery and ingestion of 100 μmole doses of sulforaphane-rich BSE (SFR-BSE), which will represent a combination of systemic and topical delivery to the oral mucosa.~3. The third regimen will isolate topical exposure of the oral mucosa to sulforaphane. Participants will swish, hold, then spit 100 μmole doses of SFR-BSE. This regimen (SFR-BSE(T)) will theoretically isolate the pharmacodynamic impact of topical exposure of the oral mucosa to sulforaphane."
Eye and Ear Institute, Pittsburgh
UPMC Hillman Cancer Center (University of Pittsburgh Cancer Institute), Pittsburgh
National Cancer Institute (NCI)
NIH
Julie E. Bauman, MD, MPH
OTHER